Christopher Staley

Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…

Gut microbiome plays a key role in human health, and the gut microbiome composition has been linked with many diseases, including colorectal cancer (CRC). The microbiome has been found to be associated with CRC progression, as well as patient outcomes…